Overview
Man Li practices in Guangzhou, China. Li is rated as a Distinguished expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Hypertension, and Pleural Effusion.
Their clinical research consists of co-authoring 70 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 16 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Small Cell Lung Cancer (SCLC)
- Experienced
- Bone TumorLi isExperienced. Learn about Bone Tumor.
- Breast CancerLi isExperienced. Learn about Breast Cancer.
- Chronic Kidney DiseaseLi isExperienced. Learn about Chronic Kidney Disease.
- COVID-19Li isExperienced. Learn about COVID-19.
- End-Stage Renal Disease (ESRD)
- HypertensionLi isExperienced. Learn about Hypertension.